Free release
Sodium 5-((3-chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylate

Sodium 5-((3-chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylate

CAS No. :1309357-15-0MDL No. :MFCD28385881Formula :C19H11ClN3NaO2Boiling Point :-Linear Structure Formula :-InChI Key :O

Sales:Service@apichina.com
CAS No. :1309357-15-0 Brand :Qitai
Formula :C19H11ClN3NaO2 M.W :371.75

Introduction

CAS No. :1309357-15-0 MDL No. :MFCD28385881
Formula : C19H11ClN3NaO2 Boiling Point : -
Linear Structure Formula :- InChI Key :ODDAAPQSODILSN-UHFFFAOYSA-M
M.W : 371.75 Pubchem ID :49788959
Synonyms :
CX-4945 sodium salt;CX-4945 Sodium
Chemical Name :Sodium 5-((3-chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylate

Physicochemical Properties

Num. heavy atoms : 26
Num. arom. heavy atoms : 20
Fraction Csp3 : 0.0
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 1.0
Molar Refractivity : 96.61
TPSA : 77.94 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : Yes
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.44 cm/s

Lipophilicity

Log Po/w (iLOGP) : -10.63
Log Po/w (XLOGP3) : 4.4
Log Po/w (WLOGP) : 3.54
Log Po/w (MLOGP) : 3.28
Log Po/w (SILICOS-IT) : 3.69
Consensus Log Po/w : 0.86

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.29
Solubility : 0.00191 mg/ml ; 0.00000515 mol/l
Class : Moderately soluble
Log S (Ali) : -5.75
Solubility : 0.000655 mg/ml ; 0.00000176 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.52
Solubility : 0.0000111 mg/ml ; 0.00000003 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 2.45
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: